Interdigitating Dendritic Cell Sarcoma — Trials

Interdigitating Dendritic Cell Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: The First Affiliated Hospital of Xiamen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–38 of 38 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07443137	CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)	not yet recruiting	Phase 1	20	Stanford UniversityOTHER	0	Aug 27, 2026	clinicaltrials
NCT07778212	Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL	recruiting	N/A	30	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Aug 21, 2026	clinicaltrials